Skip to main content
. 2022 Mar 16;37(1):876–894. doi: 10.1080/14756366.2022.2050224

Table 6.

Characteristics of echinocandins as medical preparations5,10,17,18,22,51,89,90.

Active pharmaceutical ingredient Physical form Support substances Reconstituting using Storage Dosage Treated diseases
Caspofungin acetate Lyophilised white powder, freely soluble in water (reconstitution required) Sucrose, mannitol, acetic acid, NaOH 0.9% sodium chloride solution or sterile water At temperatures less than or equal to 25 °C for 24 hours or at 2 to 8 °C for 48 hours 70 mg (saturation dose), then 50 mg daily (maintenance dose); 50 mg daily* Fungal infections in patients with fever and neutropenia, candidemia, invasive aspergillosis (in patients resistant or intolerant to other therapies); oesophageal candidiasis, intra-abdominal abscesses, peritonitis, and pleural space infections
Micafungin sodium Lyophilised powder, freely soluble in water (reconstitution required) Lactose, citric acid, NaOH 0.9% sodium chloride solution or 5% dextrose Stable for 24 hours at room temperature when protected from light No saturating dose, 100 or 50 mg daily; No saturating dose, 150 mg daily* Candidemia; oesophageal candidiasis, intra-abdominal abscesses, peritonitis, and pleural space infections
Anidulafungin Lyophilised powder, insoluble in water (reconstitution required) Fructose, mannitol, polysorbate 80, tartaric acid, NaOH or HCl 0.9% sodium chloride solution, 5% glucose solution, 20% dehydrated alcohol in water In the refrigerator up to 24 hours 200 mg (saturating dose), then 100 mg daily (maintenance doses); 100 mg (saturation dose), then 50 mg daily (maintenance dose)* Candidemia; oesophageal candidiasis, intra-abdominal abscesses, peritonitis, and pleural space infections
Rezafungin acetate Lyophilised powder, freely soluble in water (reconstitution required) Mannitol, polysorbate 80, histidine 0.9% sodium chloride solution or sterile water Stable for over an year and shows minimal degradation 400 mg first week followed by 200 mg once weekly Invasive candidiasis, aspergillosis and pneumocystis pneumonia

*Underlined special dosages are applied for oesophageal candidiasis.